The Recall Desk
LowFDA (Devices)·Z-1542-2018·Announced 2018-05-09

Ameditech Recalls Alere iScreen Dx Urine Drug Screen Cards for Labeling Error

Ameditech is recalling Alere iScreen Dx Urine Drug Screen Cards because the box label incorrectly lists Phencyclidine (PCP) instead of Tricyclic Antidepressants (TCA).

What this means for you

Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.

Our severity reasoning: The recall is classified as FDA Class III, which indicates the product is not likely to cause adverse health consequences. The issue is a minor labeling error regarding the list of drug analytes.

Plain-English summary

Ameditech Inc is recalling 828 kits (20,700 devices) of the Alere iScreen Dx Urine Drug Screen Card. The recall is due to a labeling error on the kit box, which incorrectly identifies Phencyclidine (PCP) as one of the drug analytes. The label should have listed Tricyclic Antidepressants (TCA) instead.

The affected products are identified by Part No. X11-IS10-Dx and Lot Nos. 173351, 173686, 174055, and 176002. These kits were distributed domestically to Arizona, Florida, Illinois, North Dakota, Nevada, Pennsylvania, Tennessee, Texas, and Virginia.

Consumers and healthcare facilities should check their inventory for the specific part and lot numbers listed above. If the product matches the recall description, it should be removed from use and returned to the distributor or manufacturer.

The recalled product

Product
Alere iScreen Dx Urine Drug Screen Card
Manufacturer
Ameditech Inc

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (5)

  • Part No. X11-IS10-Dx
  • Lot No. 173351
  • 173686
  • 174055
  • 176002.

Distribution

Distributed in 9 states: